Physician profile
Paul Tyan
NPI 1740696186
$3,979.07
in general payments reported to CMS, 2019-2025
31 companies · $593 in 2025
The $593 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $272 · 2022: $2,025 · 2023: $649 · 2024: $439 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,681.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,647.99 | 2022 | |
| Astellas Pharma US INC | $330.97 | 2023-2025 | Veozah |
| Organon LLC | $251.12 | 2022-2025 | Nexplanon |
| Abbvie INC. | $232.95 | 2021-2025 | Orilissa, Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $166.38 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $165.90 | 2023-2025 | Myfembree |
| Coopersurgical, INC. | $142.56 | 2022-2025 | Paragard T 380a, Wallach Cryosurgical Equipment, Endosee |
| Hologic Sales and Service, LLC | $105.59 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Myosure Tissue Removal Device, Acessa Provu System |
| Shield Therapeutics INC | $88.46 | 2025 | |
| Renovia INC | $84.12 | 2021 | |
| Dysis Medical, INC. | $73.13 | 2021-2023 | Dysis V3 Digital Coploscope, Dysis Ultra 2.0, Dysis View |
| Ethicon US, LLC | $66.58 | 2021-2022 | |
| Exact Sciences Corporation | $60.36 | 2023 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $59.54 | 2023-2024 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $58.66 | 2022-2023 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $51.49 | 2022-2025 | |
| Myovant Sciences INC. | $49.86 | 2021-2022 | |
| Aspira Women'S Health INC | $45.67 | 2022-2023 | Ova1 |
| Minerva Surgical, INC | $39.13 | 2022 | |
| Optumhealth Care Solutions, LLC | $36.88 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Avion Pharmaceuticals | $33.16 | 2022-2023 | Balcoltra |
| Abbott Laboratories | $23.33 | 2025 | Assurity |
| Becton, Dickinson and Company | $22.71 | 2024 | Bd Max System, Bd Max Instrument |
| Smith+Nephew, INC. | $21.14 | 2025 | Pico 7 |
| Seqirus USA INC | $20.08 | 2025 | Flucelvax |
| Therapeuticsmd, INC. | $18.52 | 2021 | |
| Evofem Biosciences, INC. | $18.43 | 2021 | |
| Scynexis, INC. | $18.30 | 2022 | |
| Acessa Health INC. | $17.63 | 2021 | |
| Sage Therapeutics, LLC | $15.24 | 2025 | Zurzuvae |
| Millicent US INC | $13.19 | 2024 | Intrarosa, Femring |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Tyan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.